🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
195.00
-4.33 (-2.17%)
At close: Nov 20, 2026, 4:00 PM EST
199.00
+4.00 (2.05%)
After-hours: Nov 20, 2026, 7:59 PM EST

Moderna Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2,789-2,822-3,561-4,7148,36212,202
Depreciation & Amortization
257215189621348232
Loss (Gain) From Sale of Investments
-41-59-43-263154
Stock-Based Compensation
464483429305226142
Other Operating Activities
447760728-318
Change in Accounts Receivable
-3251565344931,790-1,784
Change in Inventory
20-3483747492-1,394
Change in Accounts Payable
-10-92-6913240204
Change in Unearned Revenue
9341-439-2,060-4,1572,824
Change in Income Taxes
-----876
Change in Other Net Operating Assets
502162-1871,496-2,379582
Operating Cash Flow
-1,785-1,873-3,004-3,1184,98113,620
Operating Cash Flow Growth
-----63.43%571.93%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-185-192-1,051-707-400-284
Cash Acquisitions
----85--
Sale (Purchase) of Intangibles
-74-10----
Investment in Securities
-1,2512,1483,0005,021-4,736-8,209
Other Investing Activities
----23-40-30
Investing Cash Flow
-1,5101,9461,9494,206-5,176-8,523

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-600----
Long-Term Debt Repaid
--18-10-270-184-140
Net Debt Issued (Repaid)
3,571582-10-270-184-140
Issuance of Common Stock
18835664665124
Repurchase of Common Stock
-8-2--1,153-3,329-857
Other Financing Activities
-394-22----
Financing Cash Flow
3,35759356-1,377-3,448-873

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2----
Net Cash Flow
62668-999-289-3,6434,224

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1,970-2,065-4,055-3,8254,58113,336
Free Cash Flow Growth
-----65.65%580.75%
Free Cash Flow Margin
-78.02%-106.22%-125.31%-55.86%23.78%72.20%
Free Cash Flow Per Share
-4.97-5.31-10.56-10.0111.0130.94
Levered Free Cash Flow
-584.5-1,327-3,088-2,3593,6689,293
Unlevered Free Cash Flow
-547-1,320-3,073-2,3593,6879,304

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
101024392514
Cash Income Tax Paid
2626197-3572,729480
Change in Working Capital
280233-78689-4,0141,308
SEC Filings: 10-K · 10-Q